Number and characteristics of breast cancer cases diagnosed in four periods in the screening interval of a biennial population-based screening programme

Journal of Medical Screening

Volumn 13, Issue 4, 2006, Pages 192-196

  Hofvind, Solveig ^a,f   Bjurstam, Nils ^b,c   Sørum, Ragnhild ^a   Bjørndal, Hilde ^d   Thoresen, Steinar ^a   Skaane, Per ^e  

^a CANCER REGISTRY OF NORWAY   (Norway)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF TROMSØ   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INVASION; CANCER SCREENING; CONTROLLED STUDY; FEMALE; HEALTH PROGRAM; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PROGNOSIS; RADIODIAGNOSIS; TUMOR VOLUME;

EID: 33846035383     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1177/096914130601300406     Document Type: Article

References (32)

1. Vainio H, Bianchini F, eds. IARC Handbook of Cancer Prevention Volume 7 Breast Cancer Screening. Lyon, France: IARC Press, 2002; http://www.iarc.fr
2. Nyström L, Andersson I, Bjurstam N, et al. Long-term effects of mammography screening: updated overview of the Swedish randomized trials. Lancet 2002;359:904-5
3. Tabar L, Yen MF, Vitak B, et al. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet 2003;361:1405-10
4. Otto SJ, Fracheboud J, Looman CW, et al. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet 2003;361: 1411-17
5. Hakama M, Holli K, Isola J. Aggressiveness of screen-detected breast cancers. Lancet 1995;345:221-4
6. Wang H, Bjurstam N, Bjørndal H, et al. Interval cancers in the Norwegian breast cancer screening program: frequency, characteristics and use of HRT. Int J Cancer 2001;94:594-8
7. Ikeda DM, Andersson I, Wattsgard C, et al. Interval carcinomas in the Malmo Mammographic Screening Trial: radiographic appearance and prognostic considerations. Am J Roentgenol 1992;159:287-94
8. Shen Y, Yang Y, Inoue L, et al. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials. J Natl Cancer Inst 2005;97:1195-203
9. Hunt KA, Rosen EL, Sickles EA. Outcome analysis for women undergoing annual versus biennial screening mammography: a review of 24,211 examinations. Am J Roentgenol 1999;173:285-9
10. Field LR, Wilson TE, Strawderman M, et al. Mammographic screening in women more than 64 years old: a comparison of 1- and 2-year intervals. Am J Roentgenol 1998;170:961-5
11. Wai ES, D'yachkova Y, Olivotto IA, et al. Comparison of 1- and 2-year screening intervals for women undergoing screening mammography. Br J Cancer 2005;92:961-6
12. White E, Miglioretti DL, Yankaskas BC, et al. Biennial versus annual mammography and the risk of late-stage breast cancer. J Natl Cancer Inst 2004;96:1832-9
13. Kerlikowske K, Grady D, Rubin SM, et al. Efficacy of screening mammography. A meta-analysis. JAMA 1995;273:149-54
14. The frequency of breast cancer screening: results from the UKCCCR Randomised Trial. United Kingdom Co-ordinating Committee on Cancer Research. Eur J Cancer 2002;38:1458-64
15. Klemi PJ, Toikkanen S, Rasanen O, et al. Mammography screening interval and the frequency of interval cancers in a population-based screening. Br J Cancer 1997;75:762-6
16. Vacek PM, Geller BM, Weaver DL, et al. Increased mammography use and its impact on earlier breast cancer detection in Vermont, 1975-1999. Cancer 2002;94:2160-8
17. Miltenburg GA, Peeters PH, Fracheboud J, et al. Seventeen-year evaluation of breast cancer screening: the DOM project, The Netherlands. Diagnostisch Onderzoek (investigation) Mammacarcinoom. Br J Cancer 1998;78:962-5
18. Christiansen C, Wang F, Barton M, et al. Predicting the cumulative risk of false positive mammograms. J Natl Cancer Instit 2000;92:1657-66
19. Hofvind S, Thoresen S, Tretli S. The cumulative risk of a false-positive recall in the Norwegian Breast Cancer Screening Program. Cancer 2004;10:1501-7
20. Hofvind S, Wang H, Thoresen S. Do the results of the process indicators in the Norwegian Breast Cancer Screening Program predict future mortality reduction from breast cancer? Acta Oncol 2004;43:467-73
21. The Ministry of Health and Social Affairs. Oslo, Regulations on the Collections and Processing of the Personal Health Data in the Cancer Registry of Norway (Cancer Registry Regulations). Oslo, Norway: The Ministry of Health and Social Affairs, 2001
22. Tingulstad S, Halvorsen T, Nordstein J, et al. Completeness and accuracy of registration of ovarian cancer in the Cancer Registry of Norway. Int J Cancer 2002;98:7-11
23. ACR BI-RADS Committee. BI-RADS Breast Imagine Reporting and Data System. American College of Radiology, Reston, VA 2003
24. Tabar L, Fagerberg G, Day NE, et al. What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer 1987 A.D.;55:547-51
25. Day N, McCann J, Camilleri-Ferrante C, et al. Monitoring interval cancers in breast screening programmes: the East Angelian experience. J Med Screen 1995;2:185
26. Fracheboud J, de-Koning HJ, Beemsterboer PM, et al. Interval cancers in the Dutch breast cancer screening programme. Br J Cancer 1999;81:912-17
27. Woodman CB, Threlfall AG, Boggis CR, et al. Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's North Western region. BMJ 1995;310:224-6
28. Perry N, Broeders M, deWolf C, et al. European guidelines for quality assurance in mammography screening. Eur Commun 2001, Printed in Belgium. http://europa.eu.int
29. Schroen AA, Wobbes T, van der Sluis RF. Interval carcinomas of the breast: a group with intermediate outcome. J Surg Oncol 1996;63:141-4
30. Joensuu H, Lehtimaki T, Holli K, et al. Risk for distant recurrence of breast cancer detected by mammography screening or other methods. JAMA 2004;292:1064-73
31. Buist DS, Porter PL, Lehman C, et al. Factors contributing to mammography failure in women aged 40-49 years. J Natl Cancer Inst 2004;96:1432-40
32. Mandelson MT, Oestreicher N, Porter PL, et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 2000;92:1081-7